OncoTab (United States)
OncoTAb | Targeting Pancreatic Cancer Through tMUC1
OncoTAb is developing tMUC1-targeted therapies for pancreatic cancer, including a radiotheranostic and MUCD3, a bispecific T-cell engager.
Company details
- Address
- Charlotte, United States
- Website
- oncotab.com
Reviews
No reviews yet.
Domain and WHOIS record
- Domain
- oncotab.com
- Registrar
- GoDaddy.com, LLC
- Registered
- 1 Aug 2014
- Expires
- 1 Aug 2027
- Record updated
- 2 Aug 2026
- Name servers
- ns53.domaincontrol.com, ns54.domaincontrol.com
- DNSSEC
- Not signed